The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
-
J. Heart Lung Transplant. · Mar 1992
Comparative StudyAcute effects of dobutamine and isoproterenol after implantation of a total artificial heart.
The hemodynamic effects of dobutamine and isoproterenol infusions were studied in five Holstein calves 1 day before and 2 days after the implantation of a Jarvik-7 total artificial heart (TAH). Cardiac output was decreased, and systemic vascular resistance (SVR) and pulmonary vascular resistance were increased after TAH implantation. Administration of dobutamine before TAH implantation caused an increase in heart rate, and discontinuation of dobutamine decreased cardiac output. ⋯ Isoproterenol increased heart rate and cardiac output and decreased SVR before TAH implantation. Isoproterenol produced no significant hemodynamic effects after TAH implantation. These results describe the hemodynamic effects that could be expected from normal clinical infusions of these drugs in the patient who is supported by the TAH as a bridge to heart transplantation; these results are of additional interest in that they describe the peripheral effects of the two agents independent of cardiac effects.
-
J. Heart Lung Transplant. · Jan 1992
Summary of the clinical use of the Symbion total artificial heart: a registry report.
Several models of total artificial hearts have been used for transient or permanent circulatory support in patients with decompensation. The most successful and widely used device, however, has been the Symbion total artificial heart. From Dec. 12, 1982, to Jan. 1, 1991, 180 Symbion total artificial hearts were implanted in 176 patients in 28 centers. ⋯ The main causes of death were sepsis (33%), multiorgan failure (21%), and posttransplant rejection (10%). The results indicate a relative success of this treatment for patients with an otherwise fatal prognosis. Moreover, as the demand for donor organs far exceeds availability, continued investigation of total artificial hearts is justified.
-
J. Heart Lung Transplant. · Jan 1992
Case ReportsSuccessful transplantation of a lung allograft from a carbon monoxide-poisoning victim.
Donor availability remains the limiting factor to heart and lung transplantation. Donor selection criteria need to be continuously reassessed to expand the donor pool. The feasibility of organ donation from victims of carbon monoxide poisoning is unclear. We present a case of successful single lung transplantation from a carbon monoxide-poisoning victim.
-
J. Heart Lung Transplant. · Jan 1992
Perioperative mechanical circulatory support for transplantation.
Mechanical circulatory assistance has become a necessary supplement to more conventional means of hemodynamic support as a shortage of donor organs and associated increase in waiting time have contributed to an increased incidence of hemodynamic deterioration in potential transplant recipients. This review summarizes the experience with circulatory support before and after transplantation of the Utah Transplantation Affiliated Hospitals (UTAH) Cardiac Transplant Program and draws conclusions on the efficacy of one program's use of mechanical circulatory support. Between March 1985 and October 1990, 401 patients were accepted for first-time heart transplantation by the UTAH program. ⋯ No single factor, including either hemodynamic support before transplantation or donor heart ischemic time, was found to be predictive of the need for mechanical circulatory support after transplantation. One-year survival rates after transplantation of patients requiring mechanical circulatory support before transplantation (86%) were not significantly different than for all transplant patients (88%). The experience of the UTAH Cardiac Transplant Program shows that with the judicious use of mechanical circulatory support transplant patients with advanced forms of hemodynamic support can have as equal a probability of survival as patients who undergo elective transplantation.
-
J. Heart Lung Transplant. · Jul 1991
Comparative StudyFunctional recovery of hearts after cardioplegia and storage in University of Wisconsin and in St. Thomas' Hospital solutions.
There are conflicting reports of the beneficial effects of University of Wisconsin (UW) cardioplegic solution used in heart preservation techniques. Therefore we investigated the efficacy of myocardial protection in adult rat hearts subjected to single-dose infusion (3 minutes) of nonoxygenated cardioplegic solutions (UW or St. Thomas' Hospital solution No. 2 [STH]) and stored at 4 degrees C by immersion in the same solution or in saline solution. ⋯ In contrast, hearts arrested and stored in STH solution for 5 hours rapidly established normal left ventricular functions (aortic flow, 111.5% +/- 2.5%; cardiac output, 99.1% +/- 1.2%; coronary flow, 85.0% +/- 3.4%; heart rate, 95.8% +/- 2.7%; and aortic pressure, 94.6%). A group of hearts arrested with STH solution but stored in saline solution recovered more slowly, had only partial return of function (aortic flow, 73.6% +/- 14.8%; p less than 0.01 vs STH/STH group), and had significantly greater tissue water content (8.020 +/- 0.080 vs 6.870 +/- 0.126 ml/gm dry wt; p less than 0.01). These results demonstrate the superior preservation of explanted hearts at 4 degrees C obtained by STH cardioplegic solution compared with UW solution under conditions used for transplantation.